Pei Y. Liu
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine 2
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 4
- Molecular Biology top 5%
- RNA modifications and cancer 5
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 3
- Physiology top 5%
- Neurology top 10%
- Neuroblastoma Research and Treatments 9
-
- Autophagy in Disease and Therapy 2
- Co-authors
- Tao LiuGlenn M. MarshallJessica L. BellStefan HüttelmaierQing LanJacob HaaseAndrew E. TeeBernard Atmadibrata
- Partner nations
- AustraliaChinaUnited States
In The Last Decade
Pei Y. Liu
18 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Geriatrics and Gerontology 260
- Cancer Research 792
- Molecular Biology 1.4k
- Physiology 64
- Neurology 155
Countries citing papers authored by Pei Y. Liu
This map shows the geographic impact of Pei Y. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Y. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Y. Liu more than expected).
Fields of papers citing papers by Pei Y. Liu
This network shows the impact of papers produced by Pei Y. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Y. Liu. The network helps show where Pei Y. Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pei Y. Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 20 | |
| 2 | 2021 | 174 | |
| 3 | 2020 | 27 | |
| 4 | 2019 | 7 | |
| 5 | The Critical Role of RNA m6A Methylation in Cancerbreakdown → | 2019 | 542 |
| 6 | 2018 | 12 | |
| 7 | 2017 | 16 | |
| 8 | 2017 | 85 | |
| 9 | 2016 | 19 | |
| 10 | 2016 | 1 | |
| 11 | 2014 | 89 | |
| 12 | 2014 | 59 | |
| 13 | 2014 | 97 | |
| 14 | 2012 | 14 | |
| 15 | 2011 | 122 | |
| 16 | 2009 | 336 | |
| 17 | 2009 | 33 | |
| 18 | 2009 | 44 |
About Pei Y. Liu
Pei Y. Liu is a scholar working on Cancer Research, Neurology and Geriatrics and Gerontology, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (9 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers), Autophagy in Disease and Therapy (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Geriatrics and Gerontology (260 citations), Cancer Research (792 citations) and Molecular Biology (1.4k citations). Pei Y. Liu has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Tao Liu, Glenn M. Marshall, Jessica L. Bell, Stefan Hüttelmaier, Qing Lan, Jacob Haase, Andrew E. Tee, Bernard Atmadibrata, Xu Dong Zhang and Belamy B. Cheung.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.